← Back to Clinical Trials
Recruiting NCT07629856

NCT07629856 Effect of Cognitive-Motor Dual-Task Training on Postural Stability and Functional Mobility in Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07629856
Status Recruiting
Phase
Sponsor Riphah International University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 28 participants
Start Date 2026-05-20
Primary Completion 2026-10-20

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Cognitive-motor dual-task training (CMDT) GroupConventional Balance Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 28 participants in total. It began in 2026-05-20 with a primary completion date of 2026-10-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This Randomized Controlled Trial is conducted to investigate the effects of Cognitive-Motor Dual-Task Training on Postural Stability and Functional Mobility in Stroke Survivors.

Eligibility Criteria

Inclusion Criteria: * Age between 40-75 years. * Clinically diagnosed ischemic or hemorrhagic stroke (≥3 months,post-onset). * Ability to follow verbal commands (MMSE≥24). * Medically stable and cleared for physical activity. * Able to walk independently or with minimal assistance (Functional Ambulation Categories ≥3) * Berg Balance Scale score between 21-45 (indicating moderate fall risk). Exclusion Criteria: * Severe aphasia or language deficits impacting task comprehension. * Severe spasticity (modified Ashworth scale ≥2 in lower limbs). * Visual or vestibular impairments affecting balance. * Severe musculoskeletal conditions or orthopedic impairments that limit safe participation in balance and gait training. (e.g. recent fractures , severe arthritis). * Diagnosed Dementia or neurodegenerative disorders * Participation in any other structured dual-task or cognitive training program within the past 3 months

Contact & Investigator

Central Contact

Abrish H Abbasi, PhD* Rehab

✉ abrish.habib@riphah.edu.pk

📞 03155311799

Principal Investigator

Muattar Hina, MS-NMPT*

PRINCIPAL INVESTIGATOR

Riphah International Unversity

Frequently Asked Questions

Who can join the NCT07629856 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 75 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07629856 currently recruiting?

Yes, NCT07629856 is actively recruiting participants. Contact the research team at abrish.habib@riphah.edu.pk for enrollment information.

Where is the NCT07629856 trial being conducted?

This trial is being conducted at Chak One Hundred Fifty-seven, Pakistan.

Who is sponsoring the NCT07629856 clinical trial?

NCT07629856 is sponsored by Riphah International University. The principal investigator is Muattar Hina, MS-NMPT* at Riphah International Unversity. The trial plans to enroll 28 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology